Short Squeeze Setup — velZ +0.12 · age 21w×1.00 · 11.14%
Founder-Led — founder/CEO led
About Akebia Ther
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its product portfolio includes Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent (DD) and non-dialysis dependent (NDD) patients; and Auryxia, a ferric citrate that is used to control t… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Exchange: NASDAQ
IPO Date: March 20, 2014
Headquarters: 245 First Street, Cambridge, MA, United States, 02142
Founder-Led: Yes — John P. Butler (Chief Executive Officer, President & Director)
Key Metrics
Current Price
$1.40
Market Cap
$384M
Float
262.0M
Shares Outstanding
268.3M
P/E (Forward)
28.74
Price/Sales (TTM)
1.65
vs. Analyst Target
+200.0% to analyst PT
Profit Margin
-8.83%
Operating Margin (TTM)
-2.76%
Revenue (TTM)
$232M
Dividend Rate
None
Analyst Target Price
$4.20 (4 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$295M
-$350M
-$601,000
-$343M
2021
$214M
-$245M
$60.2M
-$227M
2022
$292M
-$94.2M
$270M
$3.1M
2023
$195M
-$51.9M
$120M
-$8.3M
2024
$160M
-$69.4M
$97.0M
-$13.7M
2025
$236M
-$5.3M
$197M
$21.7M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Jun 2025
$62.5M
$247,000
Sep 2025
$58.8M
$540,000
Dec 2025
$57.6M
-$12.2M
Mar 2026
$53.5M
-$9.1M
Ownership & Float
Insider Ownership
4.1%
Institutional Ownership
42.2%
Short Float
11.1%
% of All Funds Holding
1.91%
Number of Funds Holding
157
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$1.10
Near-term / short-term trend
Weekly
40-Week SMA
$1.50
Medium-term trend
Weekly
80-Week SMA
$2.11
Cyclical trend (business cycle)
Weekly
200-Week SMA
$1.51
Secular trend (multi-year)
Monthly
10-Month SMA
$1.44
Near-term monthly trend
Monthly
20-Month SMA
$2.05
Medium-term monthly trend
Monthly
40-Month SMA
$1.69
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$1.40
resistance
1.43x
1 months ago
$2.20
resistance
1.07x
7 months ago
$2.70
resistance
1.14x
8 months ago
Historical Earnings Reactions (49 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
-1.05%
-0.84%
32.65%
10.14%
-8.77%
1 Day
-0.38%
-1.69%
30.61%
33.73%
-15.93%
1 Week
-0.24%
-0.94%
44.90%
36.28%
-44.82%
2 Weeks
1.40%
1.83%
53.06%
66.67%
-32.73%
1 Month
0.61%
-0.84%
47.92%
95.80%
-76.29%
Next earnings: August 6, 2026 (24 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
0.7%
41.7%
12
Feb
5.0%
41.7%
12
Mar
-6.4%
50.0%
12
Apr
2.0%
46.2%
13
May
2.0%
53.8%
13
Jun
6.0%
69.2%
13
Jul
4.1%
50.0%
12
Aug
-3.6%
33.3%
12
Sep
-5.5%
33.3%
12
Oct
-12.0%
8.3%
12
Nov
13.2%
66.7%
12
Dec
8.0%
50.0%
12
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
0.06%
44.7%
580
Tuesday
0.18%
46.8%
637
Wednesday
0.30%
50.9%
634
Thursday
-0.55%
44.0%
621
Friday
0.29%
49.5%
618
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 42.2%
Insider Transactions — Smart Summary
Total insider ownership: 4.1%
Founder-led management: John P. Butler (Chief Executive Officer, President & Director)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Akebia Ther
(AKBA) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.